-
1.Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis 有权
标题翻译: 用于治疗与血管发生相关的超增殖性疾病和疾病的替代的4-氨基 - 吡咯并嗪衍生物公开(公告)号:US20090281079A1
公开(公告)日:2009-11-12
申请号:US12085879
申请日:2006-11-30
申请人: Julie Dixon , Steven Magnuson , Barton Phillips , Yamin Wang , Tandy Li , Kyle Parcella , Jason Newcom , Harold Kluender , Zhenqiu Hong , Brent Chandler , Zhonghua Zhang , Kristen Allegue , Zheng Liu
发明人: Julie Dixon , Steven Magnuson , Barton Phillips , Yamin Wang , Tandy Li , Kyle Parcella , Jason Newcom , Harold Kluender , Zhenqiu Hong , Brent Chandler , Zhonghua Zhang , Kristen Allegue , Zheng Liu
IPC分类号: A61K31/553 , C07D487/04 , A61K31/53 , A61K31/5377 , A61P35/00
CPC分类号: C07D487/04
摘要: This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis.
摘要翻译: 本发明涉及新颖的吡唑并三嗪化合物,含有这些化合物的药物组合物以及这些化合物和组合物用于预防和/或治疗与血管发生相关的高增殖性障碍和疾病的用途。
-
2.Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis 有权
标题翻译: 用于治疗高增殖性疾病和与血管发生相关的疾病的取代的4-氨基吡咯并三嗪衍生物公开(公告)号:US08133995B2
公开(公告)日:2012-03-13
申请号:US12085879
申请日:2006-11-30
申请人: Julie Dixon , Steven Magnuson , Barton Phillips , Yamin Wang , Tandy Li , Kyle Parcella , Jason Newcom , Harold Kluender , Zhenqiu Hong , Brent Chandler , Zhonghua Zhang , Kristen Allegue , Zheng Liu
发明人: Julie Dixon , Steven Magnuson , Barton Phillips , Yamin Wang , Tandy Li , Kyle Parcella , Jason Newcom , Harold Kluender , Zhenqiu Hong , Brent Chandler , Zhonghua Zhang , Kristen Allegue , Zheng Liu
IPC分类号: C07D487/04 , C07D417/02 , C07D413/02 , A61K31/53 , A61P35/00
CPC分类号: C07D487/04
摘要: This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds and compositions for the prevention and/or treatment of hyper-proliferative disorders and diseases associated with angiogenesis.
摘要翻译: 本发明涉及新颖的吡唑并三嗪化合物,含有这些化合物的药物组合物以及这些化合物和组合物用于预防和/或治疗与血管发生相关的高增殖性障碍和疾病的用途。
-